Bionano announces publication from johns hopkins school of medicine showing that ogm outperformed multiple cytogenetic assays in a study of bone and soft tissue tumor analysis

San diego, dec. 23, 2024 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced a publication in modern pathology by a group of researchers at the johns hopkins university school of medicine, showing that optical genome mapping (ogm) can outperform traditional techniques in analysis of bone and soft tissue tumors. several prior publications have shown the utility of ogm compared to traditional cytogenetics in studies of hematologic malignancies, however, data on the application of ogm in solid tumors has been relatively sparse. this study provides compelling support for extending the utility of ogm in cancer beyond hematologic malignancies to solid tumors.
BNGO Ratings Summary
BNGO Quant Ranking